Ultralife Corporation
Ultralife Corporation (ULBI) Stock Overview
Explore Ultralife Corporation’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
136.6M
P/E Ratio
25.36
EPS (TTM)
$0.31
ROE
0.04%
ULBI Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Ultralife Corporation (ULBI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 42.63, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $9.14.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 25.36 and a market capitalization of 136.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.